America Great Health reported its financial results for the six months ending December 31, 2025, revealing a net income of $1,027,321, a significant turnaround from a net loss of $340,670 during the same period in 2024. The company generated revenues of $232,659, slightly up from $231,065 in the previous year, while the cost of goods sold surged to $83,444 from $19,177, primarily due to the launch of new products in wholesale markets, which typically carry lower profit margins. Gross profit for the period was reported at $149,215, down from $211,888 in the prior year.
The company experienced notable changes in its operational metrics, including a substantial increase in selling, general, and administrative expenses, which totaled $351,374 compared to $403,261 in the previous year. This decrease was attributed to reduced payroll and professional expenses. Additionally, America Great Health recognized a non-recurring gain of $1,395,000 from the extinguishment of debt, which contributed to the positive net income for the period.
In terms of operational developments, America Great Health's inventory decreased significantly to $103,909 from $164,651, reflecting a strategic shift in product management. The company reported no accounts receivable, indicating a focus on cash sales. The total liabilities decreased to $4,908,221 from $6,045,644, while the shareholders' deficit improved to $4,715,116 from $5,743,827. The company’s cash position at the end of the reporting period was $22,904, down from $44,056 at the end of June 2025.
Looking ahead, America Great Health faces challenges related to its liquidity and ongoing operational costs, as indicated by its negative working capital of $2,404,215. The company plans to finance its operations through existing cash reserves and advances from its majority shareholder. Management has expressed the need to secure additional capital to support future growth and maintain operations, emphasizing the importance of achieving profitable operations to ensure the company's sustainability. The company’s ability to continue as a going concern remains uncertain, contingent on its success in raising funds and improving operational efficiency.
About America Great Health
America Great Health operates in the healthcare industry, focusing on research and development of protein and peptide small molecule drugs, diagnostic and medical devices with AI cloud computing, cell therapy, regenerative medicine, and manufacturing and sales of supplements. The company serves markets in the Asia Pacific and beyond through subsidiaries and joint ventures, leveraging innovative technologies and strategic investments to advance healthcare solutions.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.